CSB
CRDL

City State Bank’s Cardiol Therapeutics CRDL Stock Holding History

City State Bank’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-825
Closed -$1K – 736
2024
Q1 		$1K Hold
825
– – ﹤0.01% 676
2023
Q4 		$1K Hold
825
– – ﹤0.01% 644
2023
Q3 		$1K Hold
825
– – ﹤0.01% 656
2023
Q2 		$1K Buy
+825
New +$545 ﹤0.01% 666
2022
Q1 		– Sell
-825
Closed -$2K – 681
2021
Q4 		$2K Buy
+825
New +$2.28K ﹤0.01% 613

Other funds holding CRDL

TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
LSA
Lion Street Advisors Austin, Texas $289M AUM 3.13% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
MOS
MGO One Seven Beachwood, Ohio $4.98B AUM 22.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

City State Bank's CRDL Position: Q2 2024 in Review

City State Bank sold out of Cardiol Therapeutics (CRDL) in Q2 2024, closing a stake of 825 shares — an estimated $1K sold.

City State Bank first reported a position in CRDL in Q4 2021 and held it in 5 quarters. The position peaked at $2K in Q4 2021. 41 funds tracked by Wall St. Rank hold CRDL as of Q2 2024.

  • City State Bank reported no remaining Cardiol Therapeutics position as of Q2 2024 after selling out during the quarter.
  • City State Bank sold 825 Cardiol Therapeutics shares in Q2 2024, an estimated $1K.
  • City State Bank first reported a position in Cardiol Therapeutics in Q4 2021 and held it in 5 quarters.
  • City State Bank's Cardiol Therapeutics position peaked at $2K in Q4 2021.
  • 41 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q2 2024.

Based on City State Bank's 13F filing for Q2 2024, filed 8 Jul 2024.